Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.870
+0.050 (1.77%)
At close: Nov 14, 2025, 4:00 PM EST
2.961
+0.091 (3.17%)
After-hours: Nov 14, 2025, 7:59 PM EST
Lipocine Market Cap
Lipocine has a market cap or net worth of $15.93 million as of November 14, 2025. Its market cap has decreased by -45.06% in one year.
Market Cap
15.93M
Enterprise Value
960.17K
1-Year Change
-45.06%
Ranking
Category
Stock Price
$2.87
Market Cap Chart
Since March 21, 2014, Lipocine's market cap has decreased from $82.30M to $15.93M, a decrease of -80.64%. That is a compound annual growth rate of -13.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 15.90M | -39.08% |
| Dec 31, 2024 | 26.10M | 76.35% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -18.23% |
| Mar 21, 2014 | 82.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |